Decreased and variable systemic availability of zidovudine in patients with AIDS if administered with a meal
- 1 March 1991
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 40 (3), 305-308
- https://doi.org/10.1007/bf00315215
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related DideoxynucleosidesNew England Journal of Medicine, 1989
- Clinical Pharmacokinetics of ZidovudineClinical Pharmacokinetics, 1989
- ZidovudineDrugs, 1989
- Influences of Diet and Nutrition on Clinical PharmacokineticsClinical Pharmacokinetics, 1988
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitroAntimicrobial Agents and Chemotherapy, 1986
- ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1986
- INACTIVATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS BY HEAT, GAMMA RAYS, AND ULTRAVIOLET LIGHTThe Lancet, 1985
- Influence of food and diet on gastrointestinal drug absorption: A reviewJournal of Pharmacokinetics and Biopharmaceutics, 1977